Michael Rendl Selected Research

Neoplasms (Cancer)

7/2014	SOX2 is a cancer-specific regulator of tumour initiating potential in cutaneous squamous cell carcinoma.
9/2004	Retinoic acid increases the expression of p53 and proapoptotic caspases and sensitizes keratinocytes to apoptosis: a possible explanation for tumor preventive action of retinoids.
5/2004	Loss of vascular endothelial growth factor a activity in murine epidermal keratinocytes delays wound healing and inhibits tumor formation.
1/2004	Tcf3: a transcriptional regulator of axis induction in the early embryo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Rendl Research Topics

Disease

4	Neoplasms (Cancer) 07/2014 - 01/2004
2	Wounds and Injuries (Trauma) 01/2020 - 10/2009
1	Inflammation (Inflammations) 01/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2014
1	Tics (Tic) 07/2014
1	Skin Abnormalities 06/2012
1	Skin Diseases (Skin Disease) 09/2004
1	Skin Neoplasms (Skin Cancer) 09/2004
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 09/2004
1	Papilloma (Papillomatosis) 05/2004

Drug/Important Bio-Agent (IBA)

2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2014 - 05/2004
2	Proteins (Proteins, Gene)FDA Link 10/2009 - 01/2004
1	Tamoxifen FDA LinkGeneric 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	LipidsIBA 01/2020
1	SOXB1 Transcription FactorsIBA 07/2014
1	Phosphotransferases (Kinase)IBA 06/2012
1	RetinoidsIBA 09/2004
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 09/2004
1	CaspasesIBA 09/2004
1	benz(a)anthracene (benzanthracene)IBA 05/2004
1	CytokinesIBA 05/2004
1	CarcinogensIBA 05/2004

Therapy/Procedure

1	Therapeutics 07/2014